title: Editorial - immunotherapy for prostate cancer.
authors.forename: Bob
authors.initials: B
authors.lastname: Djavan
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D008297:Male; D011471:Prostatic Neoplasms / Q000628:therapy*; D016032:Randomized Controlled Trials as Topic; D014020:Tissue Extracts / Q000009:adverse effects / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D014020:Tissue Extracts; C511774:sipuleucel-T